Enterprise of Rosatom State Corporation
Back to website

Industry news


IBA Molecular develops educational campaign on PET/CT for oncology

IBA Molecular has initiated a campaign that aims to educate physicians about the appropriate use of PET/CT imaging for cancer and its impact on patient care. The company has developed webinars, discussions and resources addressing CMS coverage of FDG-PET/CT for oncology applications as well as assistance with claims processing.

For more information see www.smartbrief.com

comments powered by Disqus